Kevin Strang

Stock Analyst at Goldman Sachs

(1.12)

# 3,832

Out of 4,676 analysts

6

Total ratings

60%

Success rate

-5.2%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Kevin Strang

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	PRAX Praxis Precision Medicines	Rated: Buy	$470 → $575	$368.02	+56.24%	4	Aug 21, 2026
	STOK Stoke Therapeutics	Maintained: Buy	$44	$33.46	+31.50%	2	Aug 3, 2026

Praxis Precision Medicines

Aug 21, 2026

Rated: Buy

Price Target: $470 → $575

Current: $368.02

Upside: +56.24%

Stoke Therapeutics

Aug 3, 2026

Maintained: Buy

Price Target: $44

Current: $33.46

Upside: +31.50%